ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 78 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2018. The put-call ratio across all filers is 1.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,332,000 | -9.8% | 250,800 | -8.4% | 0.00% | 0.0% |
| Q4 2020 | $1,476,000 | -33.8% | 273,893 | -1.9% | 0.00% | -50.0% |
| Q3 2020 | $2,228,000 | -5.6% | 279,193 | +18.4% | 0.00% | 0.0% |
| Q2 2020 | $2,359,000 | +2742.2% | 235,707 | +672.8% | 0.00% | – |
| Q1 2020 | $83,000 | +124.3% | 30,500 | 0.0% | 0.00% | – |
| Q4 2019 | $37,000 | -19.6% | 30,500 | 0.0% | 0.00% | – |
| Q3 2019 | $46,000 | -62.6% | 30,500 | 0.0% | 0.00% | – |
| Q2 2019 | $123,000 | -19.6% | 30,500 | -14.2% | 0.00% | – |
| Q1 2019 | $153,000 | -25.4% | 35,568 | 0.0% | 0.00% | – |
| Q4 2018 | $205,000 | -58.8% | 35,568 | -3.0% | 0.00% | -100.0% |
| Q3 2018 | $497,000 | +10.7% | 36,668 | -3.0% | 0.00% | 0.0% |
| Q2 2018 | $449,000 | +56.4% | 37,796 | -12.1% | 0.00% | – |
| Q4 2017 | $287,000 | – | 42,995 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 15,832,611 | $68,080,000 | 3.54% |
| Matrix Capital Management Company, LP | 28,000,000 | $120,400,000 | 3.21% |
| Virtus ETF Advisers LLC | 50,655 | $218,000 | 0.46% |
| TFG Asset Management GP Ltd | 500,000 | $2,150,000 | 0.27% |
| Rock Springs Capital Management LP | 800,000 | $3,440,000 | 0.13% |
| Orbimed Advisors | 1,350,655 | $5,808,000 | 0.09% |
| Vident Investment Advisory, LLC | 289,340 | $1,244,000 | 0.07% |
| WS MANAGEMENT LLLP | 185,537 | $798,000 | 0.05% |
| Rathbones Group PLC | 285,722 | $1,229,000 | 0.04% |
| Tekla Capital Management LLC | 228,496 | $983,000 | 0.04% |